Clinical Outcomes From NOCD Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention

January 7, 2021 updated by: NOCD

Clinical Outcomes From NOCD Digital Behavioral Health Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention

This is a naturalistic, observational study of individuals with obsessive-compulsive disorder who were treated with exposure and response prevention via video teletherapy, augmented with between-session support with text messaging and an online community forum.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

2069

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Illinois
      • Chicago, Illinois, United States, 60601
        • Nocd, Llc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years and older (Child, Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

This is a naturalistic sample of children, adolescents, and adults with obsessive-compulsive disorder (OCD) who sought treatment for OCD from NOCD, LLC, a digital behavioral health company.

Description

Inclusion Criteria:

  • obsessive-compulsive disorder

Exclusion Criteria:

  • none

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Only
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Obsessive-Compulsive Disorder
adults, adolescents, and children with obsessive-compulsive disorder
Behavioral: Exposure and response prevention therapy
Exposures and response prevention therapy (a type of cognitive-behavioral therapy for obsessive-compulsive disorder), delivered in real-time by licensed therapists remotely via video. The treatment was augmented by between-session text messaging and online community support.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dimensional Obsessive-Compulsive Scale
Time Frame: change from pre-treatment to post-treatment (after 11 weeks)
self-rated psychometric instrument to measure symptom severity of multiple OCD subtypes
change from pre-treatment to post-treatment (after 11 weeks)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnostic Interview for Anxiety, Mood, and OCD and Related Neuropsychiatric Disorders (DIAMOND) OCD severity scale
Time Frame: pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)
clinician-rated psychometric instrument to measure overall OCD symptom severity
pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)
Depression Anxiety and Stress Scale (DASS-21)
Time Frame: pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)
self-rated psychometric instrument to measure depression, anxiety, and stress
pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)
Quality of Life Enjoyment and Satisfaction Questionnaire -- Short Form (QLES-Q)
Time Frame: pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)
self-rated psychometric instrument to measure quality of life
pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

NOCD

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2020

Primary Completion (Actual)

November 8, 2020

Study Completion (Actual)

November 8, 2020

Study Registration Dates

First Submitted

January 2, 2021

First Submitted That Met QC Criteria

January 7, 2021

First Posted (Actual)

January 8, 2021

Study Record Updates

Last Update Posted (Actual)

January 8, 2021

Last Update Submitted That Met QC Criteria

January 7, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • NOCD001

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obsessive-Compulsive Disorder

Clinical Trials on Exposure and response prevention therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe